The purpose of this study is to examine the feasibility and acceptability of a brief, nurse-led intervention to support breast cancer survivors who have delayed initiation of hormonal therapy or who have concerns about starting hormonal therapy.
This is a single-arm pilot trial to examine the feasibility and acceptability of a patient-centered, evidence-based, culturally competent, nurse-led intervention to encourage breast cancer survivors who have not begun taking adjuvant endocrine therapy (AET) to initiate the medication. The research study procedures include: * screening for eligibility * two individual study intervention sessions * study assessment follow-up questionnaires This research study involves two individual sessions with a nurse practitioner which will take place via videoconferencing sessions either in-person or via telephone. Participants will also complete three brief questionnaire packets over the 12-week course of the study. It is expected that up to 35 people will take part in this research study. The investigators plan to enrich the study sample for patients of a racial and/or ethnic minority in order to ensure the generalizability of the study findings.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Enrollment
35
One-to-One virtual (videoconference) behavioral intervention.
Massachusetts General Hospital Cancer Center
Boston, Massachusetts, United States
Dana-Farber Cancer Institute
Boston, Massachusetts, United States
Dana-Farber Cancer Institute at St Elizabeth's Medical Center
Brighton, Massachusetts, United States
Program Feasibility
Feasibility will be demonstrated by enrollment (\>50% of eligible and approached patients will enroll), retention (\>70% of enrolled participants will complete the two intervention sessions) and attendance (≥70% of participants completing at least one session).
Time frame: Up to 3 months/12 weeks
Program Acceptability
Acceptability will be demonstrated by \>75% of participants reporting average satisfaction scores greater than the mid-point of the Client Satisfaction Questionnaire. The total score range is 3-12, with higher scores indicating a better outcome.
Time frame: Up to 3 months/12 weeks
Adjuvant endocrine therapy (AET) Initiation
Following the intervention, participants will be more likely to have started their AET. AET initiation will be measured by self-reported questionnaire.
Time frame: Baseline (within 1-week of consent), 1-month, and 3-months post-baseline
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Emerson Hospital/MGH Cancer Center
Concord, Massachusetts, United States
Mass General at North Shore Cancer Center
Danvers, Massachusetts, United States
Dana-Farber Brigham Cancer Center - Foxborough
Foxborough, Massachusetts, United States
Dana-Farber Cancer Institute - Merrimack Valley
Methuen, Massachusetts, United States
Dana-Farber Brigham Cancer Center at Milford Regional Medical Center
Milford, Massachusetts, United States
Mass General at Newton Wellesley Hospital
Newton, Massachusetts, United States
Dana-Farber Brigham Cancer Center with South Shore Hospital
Weymouth, Massachusetts, United States
...and 1 more locations